Aptose Biosciences (APTO) Key Ratios

$2.03

up-down-arrow $0.02 (1.00%)

As on 01-May-2025 09:30EDT

Market cap

info icon

$4 Mln

Revenue (TTM)

info icon

$1 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

67.8

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 34.13 -- --
EBIT 83.45 90.75 52.21 17.34 1.26
Net Profit 77.20 87.10 50.66 17.23 0.64
EPS -- -- -- -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-24Dec-23Dec-22
EBIT-Margin info ----------
Net Margin info -5,368.81-28,688.06-----5,368.81
Return on equity info 104.8639.00683.23-293.96-74.70
Return on Capital info 175.5381.65875.69-275.62-73.47
Return on Assets info -147.54-110.79-220.02-159.98-62.63
Debt to Equity (x) info -----0.14-0.350.03
ROCE

875.69

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Aptose Biosciences (APTO)
875.69
-275.62
-73.47
-67.10
-51.28
Peer Median
--
--
--
--
--
ROE

683.23

--

Profit after tax / Average Net worth * 100

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Aptose Biosciences (APTO)
683.23
-293.96
-74.70
-67.67
-51.91
Peer Median
--
--
--
--
--
ROA

-220.02

--

Profit after tax / Average Total assets * 100

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Aptose Biosciences (APTO)
-220.02
-159.98
-62.63
-62.60
-48.72
Peer Median
--
--
--
--
--
Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Aptose Biosciences (APTO)
--
--
-5,368.81
-70,273.12
-10,422.26
Peer Median
--
--
--
--
--
EBIT Growth

--

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Aptose Biosciences (APTO)
--
-22.90
34.91
-16.32
-109.36
Peer Median
--
--
--
--
--
Net Profit Growth

50.34

--

Year on year growth in profit after tax

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Aptose Biosciences (APTO)
50.34
-22.44
36.01
-18.31
-110.21
Peer Median
--
--
--
--
--
Debt to Equity

-0.14

--

Total debt / Net worth

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Aptose Biosciences (APTO)
-0.14
-0.35
0.03
0.01
0.01
Peer Median
--
--
--
--
--
Short term debt to equity ratio

-0.09

--

(Short term borrowings / Net worth)

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Aptose Biosciences (APTO)
-0.09
-0.14
0.01
0.01
0.01
Peer Median
--
--
--
--
--
Current Ratio

2.14

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Aptose Biosciences (APTO)
2.14
0.78
4.03
10.00
18.36
Peer Median
--
--
--
--
--
Quick Ratio

--

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Aptose Biosciences (APTO)
--
--
--
--
--
Peer Median
--
--
--
--
--
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Aptose Biosciences (APTO)
--
--
-55.33
-711.38
-107.78
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Asset Turnover

--

--

Sales / Average Total Assets

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Aptose Biosciences (APTO)
--
--
--
--
--
Peer Median
--
--
--
--
--
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Aptose Biosciences (APTO)
--
--
--
--
--
Peer Median
--
--
--
--
--
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Aptose Biosciences (APTO)
--
3,778.38
2,890.21
1,146.35
1,167.05
Peer Median
--
--
--
--
--
EV/EBITDA

--

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Aptose Biosciences (APTO)
--
0.16
1.07
1.20
2.18
Peer Median
--
--
--
--
--
loading...
loading...